Endpoint Determination

"Endpoint Determination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Establishment of the level of a quantifiable effect indicative of a biologic process. The evaluation is frequently to detect the degree of toxic or therapeutic effect.

Descriptor ID	D023381
MeSH Number(s)	E05.315
Concept/Terms	Endpoint Determination Endpoint Determination Determination, Endpoint Determinations, Endpoint Endpoint Determinations End Point Determination Determinations, End Point End Point Determinations Point Determinations, End Endpoint Assay Endpoint Assay Assay, Endpoint Assays, Endpoint Endpoint Assays End Point Assay Assay, End Point Assays, End Point End Point Assays Point Assay, End Point Assays, End

Below are MeSH descriptors whose meaning is more general than "Endpoint Determination".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Endpoint Determination [E05.315]

Below are MeSH descriptors whose meaning is related to "Endpoint Determination".

Below are MeSH descriptors whose meaning is more specific than "Endpoint Determination".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Endpoint Determination" by people in this website by year, and whether "Endpoint Determination" was a major or minor topic of these publications.

Bar chart showing 55 publications over 17 distinct years, with a maximum of 12 publications in 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	4	4
2003	0	1	1
2004	0	1	1
2005	0	2	2
2008	0	4	4
2009	1	3	4
2010	0	3	3
2011	0	1	1
2012	0	3	3
2013	2	0	2
2014	1	2	3
2015	0	5	5
2016	0	4	4
2017	2	1	3
2018	4	8	12
2019	1	1	2
2021	1	0	1

Below are the most recent publications written about "Endpoint Determination" by people in Profiles.

Cramer SC, Wolf SL, Saver JL, Johnston KC, Mocco J, Lansberg MG, Savitz SI, Liebeskind DS, Smith W, Wintermark M, Elm JJ, Khatri P, Broderick JP, Janis S. The Utility of Domain-Specific End Points in Acute Stroke Trials. Stroke. 2021 03; 52(3):1154-1161.

View in: PubMed
Farrant M, Easton JD, Adelman EE, Cucchiara BL, Barsan WG, Tillman HJ, Elm JJ, Kim AS, Lindblad AS, Palesch YY, Zhao W, Pauls K, Walsh KB, Martí-Fàbregas J, Bernstein RA, Johnston SC. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis. JAMA Netw Open. 2019 09 04; 2(9):e1910769.

View in: PubMed
Yu Z, Ramakrishnan V, Meinzer C. Simulation optimization for Bayesian multi-arm multi-stage clinical trial with binary endpoints. J Biopharm Stat. 2019; 29(2):306-317.

View in: PubMed
Kimberly WT, Bevers MB, von Kummer R, Demchuk AM, Romero JM, Elm JJ, Hinson HE, Molyneaux BJ, Simard JM, Sheth KN. Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial. Neurology. 2018 12 04; 91(23):e2163-e2169.

View in: PubMed
Casella JF, Adams RJ, Brambilla DJ, Strouse JJ, Maier P, Dlugash R, Avadhani R, Vermillion K, Tonascia J, Voeks JH, Hanley DF, Thompson RE, Lehmann HP. Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease. Clin Trials. 2019 02; 16(1):20-31.

View in: PubMed
Knox J, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Scodes J, Anton R, Hasin DS. Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General Population. Alcohol Clin Exp Res. 2018 11; 42(11):2256-2265.

View in: PubMed
Maron DJ, Harrington RA, Hochman JS. Planning and Conducting the ISCHEMIA Trial. Circulation. 2018 10 02; 138(14):1384-1386.

View in: PubMed
Ward RC, Taber DJ, Axon RN, Gebregziabher M. Investigating the Potential for Bias When Using a Widely Accepted Medication Adherence Measure to Predict Mortality. Pharmacotherapy. 2018 11; 38(11):1086-1094.

View in: PubMed
Dmochowski RR, Rovner ES, Connors KG, Winters JC. Study design and outcomes measures: The influence of composite endpoints and other design variables on outcomes in a study of a novel device for stress urinary incontinence. Neurourol Urodyn. 2018 11; 37(8):2919-2927.

View in: PubMed
Donnenfeld ED, Solomon KD, Matossian C. Safety of IBI-10090 for inflammation associated with cataract surgery: Phase 3 multicenter study. J Cataract Refract Surg. 2018 Oct; 44(10):1236-1246.

View in: PubMed

People

Explore

Similar Concepts

Top Journals